Activity value 90england Buyer&Supplier,Last transaction date:
2025-12-08Address: estados unidos,philadelphia,10381 decatur road philadelphia, pa
Overview
Contact
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for catalent pharma solutions from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 11 transactions, with a transaction quantity of 2570.03 and a transaction weight of 0.
Product description
PERTUZUMAB EXPRESSING CHO CELL LINE GPEX LIGHTNENING CLONE 255 10 G PERTUZUMAB EXPRESSING CHO CELL LINE GPEX LIGHNENING CLONE
Expand
Product description
PERTUZUMAB EXPRESSING CHO CELL LINE GPEX LIGHTNENING CLONE 332 10 G PERTUZUMAB EXPRESSING CHO CELL LINE GPEX LIGHNENING CLONE
Expand
Product description
PERTUZUMAB EXPRESSING CHO CELL LINE GPEX LIGHTNENING CLONE 1708 10 G PERTUZUMAB EXPRESSING CHO CELL LINE GPEX LIGHNENING CLONE
Expand
Trade date
2025/09/01
B/L No.
2642174
Suppliers
catalent pharma solutions
Buyers
syngene international ltd.
catalent pharma solutions is england Buyer&Supplier,
and primarily engages in the import and export business of products such as lysi,clinical trial,asim.
According to the 52wmb.com global trade database, as of 2025-12-08, the company has completed 2551 international trades,
with its main trading regions covering ukraine,peru,argentina etc.
The core products include HS30049099,HS30049000,HS30043900 etc,
often transported via philadelphia,port miami, port naples etc,
and its main trading partners are novartis biosciences peru s.a.,wyeth s.a.,тов ворлдвайд клінікал траілс укр.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on catalent pharma solutions is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.